| 摘要 |
The present invention provides an ameliorating agent for symptoms resulting from joint diseases relating to PTH or PTHrP. It was found that joint diseases and symptoms resulting from joint diseases could be ameliorated by a substance capable of inhibiting the binding between parathyroid hormone related peptide and a receptor thereof. This has led to the completion of the present invention. More specifically, the present invention provides an ameliorating agent for symptoms resulting from joint diseases, which comprises, as an active ingredient, a substance capable of inhibiting the binding between parathyroid hormone related peptide and a receptor thereof.
|
